A comprehensive view of biopharmaceuticals / biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
South Korea's Ministry of Trade, Industry and Energy discusses investment opportunities with Thermo Fisher Scientific for a raw biomaterials facility; South Korea aiming to become a global pharmaceutical manufacturing giant
Published:
March 28, 2024
by Contify Investment News
|
Eurofins outlines highlights from H2 2023, including organic core business growth, opening of new facilities
Published:
March 27, 2024
by Industry Intelligence Inc.
|
Non profit Caring Cross partners with Brazilian government and Fiocruz to provide access to cutting-edge cell and gene therapies for diseases such as leukemia and HIV; group seeks to develop and manufacture drugs at a fraction of cost to make them in US
Published:
March 27, 2024
by FiercePharma
|
Charles River partners with Singapore's Yong Loo Lin School of Medicine to develop and manufacture plasmid DNA for engineered stem cell cancer therapy; partnership to use Charles River's CDMO expertise in HQ and GMP-compliant plasmid DNA
Published:
March 26, 2024
by Zack's Commentary
|
AbbVie to acquire Landos Biopharma for an estimated US$212.5M; deal includes NX-13, a potentially ground-breaking oral treatment for conditions such as ulcerative colitis and Crohn's disease
Published:
March 25, 2024
by AbbVie Inc.
|
Ask us about our Health Care Sector market view